ClinicalTrials.Veeva

Menu

Development and Validation of a Clinical Risk Prediction Model for Early Acute Kidney Injury Within 48 Hours After Liver Transplantation

B

Beijing Tsinghua Chang Gung Hospital

Status

Completed

Conditions

Liver Transplantation
Model
Acute Kidney Injury

Treatments

Diagnostic Test: KDIGO CRITERIA

Study type

Observational

Funder types

Other

Identifiers

NCT06750770
22216-4-01

Details and patient eligibility

About

Acute kidney injury (AKI) is a common complication after liver transplantation, with an incidence of 12.7-95%. The occurrence of acute kidney injury after transplantation is related to the poor prognosis of patients, which significantly increases the length of hospital stay, hospitalization costs and mortality of patients. Early recognition of acute kidney injury after transplantation is of great significance. Therefore, by collecting preoperative and intraoperative variables, this study intends to establish and verify a clinical risk prediction model for early AKI after liver transplantation, in order to provide clinicians with a visual prediction tool to identify patients with high risk of early AKI after liver transplantation immediately after the operation, so as to start clinical intervention as soon as possible and improve the prognosis of patients.

Enrollment

453 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who underwent liver transplantation in Beijing Tsinghua Changgung Hospital.

Exclusion criteria

  • (1) under 18 years of age (2) post-renal transplant (3) liver combined with other organ transplants (4) preoperative requirement for renal replacement therapy (RRT) (5) patients with second or multiple liver transplants (6) preoperative estimated glomerular filtration rate (eGFR) <60 mL/min/1.73m2, and (7) patients with severe illness leading to termination of surgery.

Trial design

453 participants in 2 patient groups

AKI group
Description:
Participants who were diagnosed acute kidney injury(AKI)
Treatment:
Diagnostic Test: KDIGO CRITERIA
Non-AKI group
Description:
Participants who were not diagnosed AKI
Treatment:
Diagnostic Test: KDIGO CRITERIA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems